MedTrace Logo

Feasibility Testing of the "MyGlucoCare" Smartphone App for Women With Gestational Diabetes

NCT07372872 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2026-05-22

No results posted yet for this study

Summary

The goal of this pilot study is to test the feasibility and preliminary impact of "MyGlucoCare," a smartphone-based program designed to support women with gestational diabetes (GDM). The main questions it aims to answer are:

Is the "MyGlucoCare" program practical and acceptable for participants?

Does it show preliminary signs of improving self-management, blood sugar control, and well-being in women with gestational diabetes (GDM)?

Researchers will conduct a single-arm study to gather initial data on the program's use and effects, which will be used to plan a larger future clinical trial.

Participants will:

Use the "MyGlucoCare" app for 8-12 weeks during their pregnancy.

Receive personalized education, support from a clinician, and access to a moderated peer group through the app.

Complete questionnaires and log health data via the app at the start, near the end of pregnancy, and after giving birth.

Some participants will also take part in an interview to share their feedback on the program.

Conditions

  • Gestational Diabetes Mellitus (GDM)

Interventions

DEVICE

MyGlucoCare

The "MyGlucoCare" intervention is a comprehensive, technology-facilitated program delivered over 8 to 12 weeks. It integrates three core components to provide holistic and personalised support for women with gestational diabetes (GDM).

Sponsors & Collaborators

  • Hong Kong Metropolitan University

    lead OTHER

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-05-01
Primary Completion
2026-11-30
Completion
2026-11-30

Countries

  • Hong Kong

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07372872 on ClinicalTrials.gov